GlycoMimetics Inc (GLYC)
1.71
-0.14
(-7.82%)
USD |
NASDAQ |
Apr 25, 16:00
1.70
-0.01
(-0.58%)
After-Hours: 20:00
GlycoMimetics Total Assets (Quarterly): 45.32M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 45.32M |
| September 30, 2023 | 53.20M |
| June 30, 2023 | 61.82M |
| March 31, 2023 | 68.92M |
| December 31, 2022 | 51.81M |
| September 30, 2022 | 55.96M |
| June 30, 2022 | 65.04M |
| March 31, 2022 | 81.46M |
| December 31, 2021 | 94.35M |
| September 30, 2021 | 107.94M |
| June 30, 2021 | 124.38M |
| March 31, 2021 | 138.02M |
| December 31, 2020 | 142.83M |
| September 30, 2020 | 150.42M |
| June 30, 2020 | 158.35M |
| March 31, 2020 | 162.10M |
| December 31, 2019 | 167.97M |
| September 30, 2019 | 180.45M |
| June 30, 2019 | 192.33M |
| March 31, 2019 | 204.44M |
| December 31, 2018 | 214.84M |
| September 30, 2018 | 225.17M |
| Date | Value |
|---|---|
| June 30, 2018 | 235.70M |
| March 31, 2018 | 247.42M |
| December 31, 2017 | 128.58M |
| September 30, 2017 | 115.82M |
| June 30, 2017 | 121.62M |
| March 31, 2017 | 37.17M |
| December 31, 2016 | 42.39M |
| September 30, 2016 | 48.01M |
| June 30, 2016 | 55.77M |
| March 31, 2016 | 40.70M |
| December 31, 2015 | 48.46M |
| September 30, 2015 | 55.74M |
| June 30, 2015 | 62.04M |
| March 31, 2015 | 48.46M |
| December 31, 2014 | 57.26M |
| September 30, 2014 | 62.43M |
| June 30, 2014 | 67.52M |
| March 31, 2014 | 58.06M |
| December 31, 2013 | 5.284M |
| September 30, 2013 | 9.561M |
| June 30, 2013 | 11.55M |
| December 31, 2012 | 18.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
45.32M
Minimum
Dec 2023
192.33M
Maximum
Jun 2019
110.67M
Average
107.94M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Altimmune Inc | 210.64M |
| Cellectar Biosciences Inc | 12.08M |
| PDS Biotechnology Corp | 59.39M |
| Syros Pharmaceuticals Inc | 168.17M |
| Precision BioSciences Inc | 159.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.902M |
| Shareholders Equity (Quarterly) | 38.41M |
| Current Ratio | 6.407 |